Find News

Filter articles

Applied Filters

Showing 1 to 10 of 278 results

10x Genomics 'overjoyed' to win UPC preliminary injunction

EU19-09-2023Legal developmentsSarah Speight

Decision marks first announcement by the UPC of an injunction in open court | Ruling in Munich Local Division forecast to have far-reaching consequences for defendant| Comment from 10x vice president of IP and litigation, Randy Wu.

Harvard and 10x to face anti-competitive claims over genomics patents

US13-07-2023Liz Hockley

Delaware court permits counterclaims from Vizgen and Nanostring in separate suits | Firms say patents-in-suit were covered by ‘open and non-exclusive licenses’.

Vizgen accuses Harvard and 10x of patent licence cover-up

US04-05-2023Legal developmentsLiz Hockley

Firm says patents-in-suit were developed using $19 million of public money | Biotech also cites “new evidence” in suit with Harvard and 10x.

Biotech escalates genetic analysis tech dispute

US24-10-2022Staff Writer

The complaint centres on profiling tech used in genetic analysis | Last year, 10x Genomics accused NanoString of infringing multiple patents related to spatial profiling.

Illumina urges court to overturn DNA patent verdict


Biotech company Illumina has asked a Delaware court to overturn a finding that it willfully infringed two DNA sequencing patents and must pay $334 million in damages.

OptraHealth sues Invitae over genetic testing chatbot

US24-05-2022Muireann Bolger

OptraHealth has filed a patent infringement lawsuit against Invitae that centres on the latter’s Gia chatbot that offers genetic testing and advice.

BGI hit with $8m damages bill in patent dispute with Illumina

02-12-2021Muireann Bolger

Illumina has secured an $8 million damages verdict against China-based BGI Genomics, and its US subsidiary, MGI, in a dispute involving gene-sequencing patents.

WIPO unveils course on genetic resources in the life sciences

International06-05-2021Muireann Bolger

The World Intellectual Property Office has launched a course on IP and genetic resources in the life sciences.

Fed Circ. affirms Stanford genetics patent rejection

US26-03-2021Alex Baldwin

The Federal Circuit has affirmed a Patent Trial and Appeal Board decision denying Stanford University a patent application for calculating parent genes.

Fed Circuit rejects Stanford Uni’s ‘abstract’ genetics patent

US15-03-2021Rory O'Neill

Stanford University can’t patent a genetic testing method as it is based on “abstract mathematical calculations”, the US Court of Appeals for the Federal Circuit has ruled.

Showing 1 to 10 of 278 results